Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA Cancer J Clin 2024;74:12–49.

• PubMed
Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA Cancer J Clin 2024;74:12–49.)| false
• Search Google Scholar
• Export Citation

Cheng L, Eng C, Nieman LZ, et al. Trends in colorectal cancer incidence by anatomic site and disease stage in the United States from 1976 to 2005. Am J Clin Oncol 2011;34:573–580.

• PubMed
Cheng L, Eng C, Nieman LZ, Trends in colorectal cancer incidence by anatomic site and disease stage in the United States from 1976 to 2005. Am J Clin Oncol 2011;34:573–580.)| false
• Search Google Scholar
• Export Citation

Siegel RL, Miller KD, Goding Sauer A, et al. Colorectal cancer statistics, 2020. CA Cancer J Clin 2020;70:145–164.

• PubMed
Siegel RL, Miller KD, Goding Sauer A, Colorectal cancer statistics, 2020. CA Cancer J Clin 2020;70:145–164.)| false
• Search Google Scholar
• Export Citation

Bailey CE, Hu CY, You YN, et al. Increasing disparities in the age-related incidences of colon and rectal cancers in the United States, 1975–2010. JAMA Surg 2014;150:17–22.

• PubMed
Bailey CE, Hu CY, You YN, Increasing disparities in the age-related incidences of colon and rectal cancers in the United States, 1975–2010. JAMA Surg 2014;150:17–22.)| false
• Search Google Scholar
• Export Citation

Weinberg BA, Marshall JL, Salem ME. The growing challenge of young adults with colorectal cancer. Oncology (Williston Park) 2017;31:381–389.

• PubMed
Weinberg BA, Marshall JL, Salem ME. The growing challenge of young adults with colorectal cancer. Oncology (Williston Park) 2017;31:381–389.)| false
• Search Google Scholar
• Export Citation

Meng L, Thapa R, Delgado MG, et al. Association of age with treatment-related adverse events and survival in patients with metastatic colorectal cancer. JAMA Netw Open 2023;6:e2320035.

• PubMed
Meng L, Thapa R, Delgado MG, Association of age with treatment-related adverse events and survival in patients with metastatic colorectal cancer. JAMA Netw Open 2023;6:e2320035.)| false
• Search Google Scholar
• Export Citation

Cercek A, Chatila WK, Yaeger R, et al. A comprehensive comparison of early-onset and average-onset colorectal cancers. J Natl Cancer Inst 2021;113:1683–1692.

• PubMed
Cercek A, Chatila WK, Yaeger R, A comprehensive comparison of early-onset and average-onset colorectal cancers. J Natl Cancer Inst 2021;113:1683–1692.)| false
• Search Google Scholar
• Export Citation

Yin J, Salem ME, Dixon JG, et al. Reevaluating disease-free survival as an endpoint vs overall survival in stage III adjuvant colon cancer trials. J Natl Cancer Inst 2022;114:60–67.

• PubMed
Yin J, Salem ME, Dixon JG, Reevaluating disease-free survival as an endpoint vs overall survival in stage III adjuvant colon cancer trials. J Natl Cancer Inst 2022;114:60–67.)| false
• Search Google Scholar
• Export Citation

Wang AY, Hwang JH, Bhatt A, Draganov PV. AGA clinical practice update on surveillance after pathologically curative endoscopic submucosal dissection of early gastrointestinal neoplasia in the United States: commentary. Gastroenterology 2021;161:2030–2040.e1.

• PubMed
Wang AY, Hwang JH, Bhatt A, Draganov PV. AGA clinical practice update on surveillance after pathologically curative endoscopic submucosal dissection of early gastrointestinal neoplasia in the United States: commentary. Gastroenterology 2021;161:2030–2040.e1.)| false
• Search Google Scholar
• Export Citation

Draganov PV, Wang AY, Othman MO, Fukami N. AGA Institute clinical practice update: endoscopic submucosal dissection in the United States. Clin Gastroenterol Hepatol 2019;17:16–25.e1.

• PubMed
Draganov PV, Wang AY, Othman MO, Fukami N. AGA Institute clinical practice update: endoscopic submucosal dissection in the United States. Clin Gastroenterol Hepatol 2019;17:16–25.e1.)| false
• Search Google Scholar
• Export Citation

Draganov PV, Coman RM, Gotoda T. Training for complex endoscopic procedures: how to incorporate endoscopic submucosal dissection skills in the West? Expert Rev Gastroenterol Hepatol 2014;8:119–121.

• PubMed
Draganov PV, Coman RM, Gotoda T. Training for complex endoscopic procedures: how to incorporate endoscopic submucosal dissection skills in the West? Expert Rev Gastroenterol Hepatol 2014;8:119–121.)| false
• Search Google Scholar
• Export Citation

Mann R, Gajendran M, Umapathy C, et al. Endoscopic management of complex colorectal polyps: current insights and future trends. Front Med (Lausanne) 2021;8:728704.

• PubMed
Mann R, Gajendran M, Umapathy C, Endoscopic management of complex colorectal polyps: current insights and future trends. Front Med (Lausanne) 2021;8:728704.)| false
• Search Google Scholar
• Export Citation

Draganov PV, Aihara H, Karasik MS, et al. Endoscopic submucosal dissection in North America: a large prospective multicenter study. Gastroenterology 2021;160:2317–2327.e2.

• PubMed
Draganov PV, Aihara H, Karasik MS, Endoscopic submucosal dissection in North America: a large prospective multicenter study. Gastroenterology 2021;160:2317–2327.e2.)| false
• Search Google Scholar
• Export Citation

Yang D, Draganov PV. Endoscopic submucosal dissection in 2018: a minimally invasive curative approach for select rectal cancers. Am J Gastroenterol 2019;114:687.

• PubMed
Yang D, Draganov PV. Endoscopic submucosal dissection in 2018: a minimally invasive curative approach for select rectal cancers. Am J Gastroenterol 2019;114:687.)| false
• Search Google Scholar
• Export Citation

Atallah C, Taylor JP, Lo BD, et al. Local excision for T1 rectal tumours: are we getting better? Colorectal Dis 2020;22:2038–2048.

• PubMed
Atallah C, Taylor JP, Lo BD, Local excision for T1 rectal tumours: are we getting better? Colorectal Dis 2020;22:2038–2048.)| false
• Search Google Scholar
• Export Citation

Dekkers N, Boonstra JJ, Moons LMG, et al. Transanal minimally invasive surgery (TAMIS) versus endoscopic submucosal dissection (ESD) for resection of non-pedunculated rectal lesions (TRIASSIC study): study protocol of a European multicenter randomised controlled trial. BMC Gastroenterol 2020;20:225.

• PubMed
Dekkers N, Boonstra JJ, Moons LMG, Transanal minimally invasive surgery (TAMIS) versus endoscopic submucosal dissection (ESD) for resection of non-pedunculated rectal lesions (TRIASSIC study): study protocol of a European multicenter randomised controlled trial. BMC Gastroenterol 2020;20:225.)| false
• Search Google Scholar
• Export Citation

Kim M, Bareket R, Eleftheriadis NP, et al. Endoscopic submucosal dissection (ESD) offers a safer and more cost-effective alternative to transanal endoscopic microsurgery (TEM): an international collaborative study. J Clin Gastroenterol 2023;57:486–489.

• PubMed
Kim M, Bareket R, Eleftheriadis NP, Endoscopic submucosal dissection (ESD) offers a safer and more cost-effective alternative to transanal endoscopic microsurgery (TEM): an international collaborative study. J Clin Gastroenterol 2023;57:486–489.)| false
• Search Google Scholar
• Export Citation

Kiriyama S, Saito Y, Matsuda T, et al. Comparing endoscopic submucosal dissection with transanal resection for non-invasive rectal tumor: a retrospective study. J Gastroenterol Hepatol 2011;26:1028–1033.

• PubMed
Kiriyama S, Saito Y, Matsuda T, Comparing endoscopic submucosal dissection with transanal resection for non-invasive rectal tumor: a retrospective study. J Gastroenterol Hepatol 2011;26:1028–1033.)| false
• Search Google Scholar
• Export Citation

Park SU, Min YW, Shin JU, et al. Endoscopic submucosal dissection or transanal endoscopic microsurgery for nonpolypoid rectal high grade dysplasia and submucosa-invading rectal cancer. Endoscopy 2012;44:1031–1036.

• PubMed
Park SU, Min YW, Shin JU, Endoscopic submucosal dissection or transanal endoscopic microsurgery for nonpolypoid rectal high grade dysplasia and submucosa-invading rectal cancer. Endoscopy 2012;44:1031–1036.)| false
• Search Google Scholar
• Export Citation

Sagae VMT, Ribeiro IB, de Moura DTH, et al. Endoscopic submucosal dissection versus transanal endoscopic surgery for the treatment of early rectal tumor: a systematic review and meta-analysis. Surg Endosc 2020;34:1025–1034.

• PubMed
Sagae VMT, Ribeiro IB, de Moura DTH, Endoscopic submucosal dissection versus transanal endoscopic surgery for the treatment of early rectal tumor: a systematic review and meta-analysis. Surg Endosc 2020;34:1025–1034.)| false
• Search Google Scholar
• Export Citation

Tanaka S, Kashida H, Saito Y, et al. Japan Gastroenterological Endoscopy Society guidelines for colorectal endoscopic submucosal dissection/endoscopic mucosal resection. Dig Endosc 2020;32:219–239.

• PubMed
Tanaka S, Kashida H, Saito Y, Japan Gastroenterological Endoscopy Society guidelines for colorectal endoscopic submucosal dissection/endoscopic mucosal resection. Dig Endosc 2020;32:219–239.)| false
• Search Google Scholar
• Export Citation

Kobayashi H, Mochizuki H, Morita T, et al. Characteristics of recurrence after curative resection for T1 colorectal cancer: Japanese multicenter study. J Gastroenterol 2011;46:203–211.

• PubMed
Kobayashi H, Mochizuki H, Morita T, Characteristics of recurrence after curative resection for T1 colorectal cancer: Japanese multicenter study. J Gastroenterol 2011;46:203–211.)| false
• Search Google Scholar
• Export Citation

Ikematsu H, Yoda Y, Matsuda T, et al. Long-term outcomes after resection for submucosal invasive colorectal cancers. Gastroenterology 2013;144:551–559.

• PubMed
Ikematsu H, Yoda Y, Matsuda T, Long-term outcomes after resection for submucosal invasive colorectal cancers. Gastroenterology 2013;144:551–559.)| false
• Search Google Scholar
• Export Citation

Yang D, Aihara H, Perbtani YB, et al. Safety and efficacy of endoscopic submucosal dissection for rectal neoplasia: a multicenter North American experience. Endosc Int Open 2019;7:e1714–1722.

• PubMed
Yang D, Aihara H, Perbtani YB, Safety and efficacy of endoscopic submucosal dissection for rectal neoplasia: a multicenter North American experience. Endosc Int Open 2019;7:e1714–1722.)| false
• Search Google Scholar
• Export Citation

Repici A, Hassan C, Pagano N, et al. High efficacy of endoscopic submucosal dissection for rectal laterally spreading tumors larger than 3 cm. Gastrointest Endosc 2013;77:96–101.

• PubMed
Repici A, Hassan C, Pagano N, High efficacy of endoscopic submucosal dissection for rectal laterally spreading tumors larger than 3 cm. Gastrointest Endosc 2013;77:96–101.)| false
• Search Google Scholar
• Export Citation

Probst A, Ebigbo A, Markl B, et al. Endoscopic submucosal dissection for rectal neoplasia extending to the dentate line: European experience. Endosc Int Open 2018;6:e1355–1362.

• PubMed
Probst A, Ebigbo A, Markl B, Endoscopic submucosal dissection for rectal neoplasia extending to the dentate line: European experience. Endosc Int Open 2018;6:e1355–1362.)| false
• Search Google Scholar
• Export Citation

Oka S, Tanaka S, Saito Y, et al. Local recurrence after endoscopic resection for large colorectal neoplasia: a multicenter prospective study in Japan. Am J Gastroenterol 2015;110:697–707.

• PubMed
Oka S, Tanaka S, Saito Y, Local recurrence after endoscopic resection for large colorectal neoplasia: a multicenter prospective study in Japan. Am J Gastroenterol 2015;110:697–707.)| false
• Search Google Scholar
• Export Citation

Cercek A, Goodman KA, Hajj C, et al. Neoadjuvant chemotherapy first, followed by chemoradiation and then surgery, in the management of locally advanced rectal cancer. J Natl Compr Canc Netw 2014;12:513–519.

• PubMed
Cercek A, Goodman KA, Hajj C, Neoadjuvant chemotherapy first, followed by chemoradiation and then surgery, in the management of locally advanced rectal cancer. J Natl Compr Canc Netw 2014;12:513–519.)| false
• Search Google Scholar
• Export Citation

Chau I, Brown G, Cunningham D, et al. Neoadjuvant capecitabine and oxaliplatin followed by synchronous chemoradiation and total mesorectal excision in magnetic resonance imaging-defined poor-risk rectal cancer. J Clin Oncol 2006;24:668–674.

• PubMed
Chau I, Brown G, Cunningham D, Neoadjuvant capecitabine and oxaliplatin followed by synchronous chemoradiation and total mesorectal excision in magnetic resonance imaging-defined poor-risk rectal cancer. J Clin Oncol 2006;24:668–674.)| false
• Search Google Scholar
• Export Citation

Fernandez-Martos C, Pericay C, Aparicio J, et al. Phase II, randomized study of concomitant chemoradiotherapy followed by surgery and adjuvant capecitabine plus oxaliplatin (CAPOX) compared with induction CAPOX followed by concomitant chemoradiotherapy and surgery in magnetic resonance imaging-defined, locally advanced rectal cancer: Grupo Cancer de Recto 3 study. J Clin Oncol 2010;28:859–865.

• PubMed
Fernandez-Martos C, Pericay C, Aparicio J, Phase II, randomized study of concomitant chemoradiotherapy followed by surgery and adjuvant capecitabine plus oxaliplatin (CAPOX) compared with induction CAPOX followed by concomitant chemoradiotherapy and surgery in magnetic resonance imaging-defined, locally advanced rectal cancer: Grupo Cancer de Recto 3 study. J Clin Oncol 2010;28:859–865.)| false
• Search Google Scholar
• Export Citation

Perez K, Safran H, Sikov W, et al. Complete neoadjuvant treatment for rectal cancer: the Brown University Oncology Group CONTRE study. Am J Clin Oncol 2014;40:283–287.

• PubMed
Perez K, Safran H, Sikov W, Complete neoadjuvant treatment for rectal cancer: the Brown University Oncology Group CONTRE study. Am J Clin Oncol 2014;40:283–287.)| false
• Search Google Scholar
• Export Citation

Marechal R, Vos B, Polus M, et al. Short course chemotherapy followed by concomitant chemoradiotherapy and surgery in locally advanced rectal cancer: a randomized multicentric phase II study. Ann Oncol 2012;23:1525–1530.

• PubMed
Marechal R, Vos B, Polus M, Short course chemotherapy followed by concomitant chemoradiotherapy and surgery in locally advanced rectal cancer: a randomized multicentric phase II study. Ann Oncol 2012;23:1525–1530.)| false
• Search Google Scholar
• Export Citation

Nogue M, Salud A, Vicente P, et al. Addition of bevacizumab to XELOX induction therapy plus concomitant capecitabine-based chemoradiotherapy in magnetic resonance imaging-defined poor-prognosis locally advanced rectal cancer: the AVACROSS study. Oncologist 2011;16:614–620.

• PubMed
Nogue M, Salud A, Vicente P, Addition of bevacizumab to XELOX induction therapy plus concomitant capecitabine-based chemoradiotherapy in magnetic resonance imaging-defined poor-prognosis locally advanced rectal cancer: the AVACROSS study. Oncologist 2011;16:614–620.)| false
• Search Google Scholar
• Export Citation

Fernandez-Martos C, Garcia-Albeniz X, Pericay C, et al. Chemoradiation, surgery and adjuvant chemotherapy versus induction chemotherapy followed by chemoradiation and surgery: long-term results of the Spanish GCR-3 phase II randomized trial. Ann Oncol 2015;26:1722–1728.

• PubMed
Fernandez-Martos C, Garcia-Albeniz X, Pericay C, Chemoradiation, surgery and adjuvant chemotherapy versus induction chemotherapy followed by chemoradiation and surgery: long-term results of the Spanish GCR-3 phase II randomized trial. Ann Oncol 2015;26:1722–1728.)| false
• Search Google Scholar
• Export Citation

Sclafani F, Brown G, Cunningham D, et al. PAN-EX: a pooled analysis of two trials of neoadjuvant chemotherapy followed by chemoradiotherapy in MRI-defined, locally advanced rectal cancer. Ann Oncol 2016;27:1557–1565.

• PubMed
Sclafani F, Brown G, Cunningham D, PAN-EX: a pooled analysis of two trials of neoadjuvant chemotherapy followed by chemoradiotherapy in MRI-defined, locally advanced rectal cancer. Ann Oncol 2016;27:1557–1565.)| false
• Search Google Scholar
• Export Citation

Garcia-Aguilar J, Chow OS, Smith DD, et al. Effect of adding mFOLFOX6 after neoadjuvant chemoradiation in locally advanced rectal cancer: a multicentre, phase 2 trial. Lancet Oncol 2015;16:957–966.

• PubMed
Garcia-Aguilar J, Chow OS, Smith DD, Effect of adding mFOLFOX6 after neoadjuvant chemoradiation in locally advanced rectal cancer: a multicentre, phase 2 trial. Lancet Oncol 2015;16:957–966.)| false
• Search Google Scholar
• Export Citation

Cercek A, Roxburgh CSD, Strombom P, et al. Adoption of total neoadjuvant therapy for locally advanced rectal cancer. JAMA Oncol 2018;4:e180071.

• PubMed
Cercek A, Roxburgh CSD, Strombom P, Adoption of total neoadjuvant therapy for locally advanced rectal cancer. JAMA Oncol 2018;4:e180071.)| false
• Search Google Scholar
• Export Citation

Kasi A, Abbasi S, Handa S, et al. Total neoadjuvant therapy vs standard therapy in locally advanced rectal cancer: a systematic review and meta-analysis. JAMA Netw Open 2020;3:e2030097.

• PubMed
Kasi A, Abbasi S, Handa S, Total neoadjuvant therapy vs standard therapy in locally advanced rectal cancer: a systematic review and meta-analysis. JAMA Netw Open 2020;3:e2030097.)| false
• Search Google Scholar
• Export Citation

Petrelli F, Trevisan F, Cabiddu M, et al. Total neoadjuvant therapy in rectal cancer: a systematic review and meta-analysis of treatment outcomes. Ann Surg 2020;271:440–448.

• PubMed
Petrelli F, Trevisan F, Cabiddu M, Total neoadjuvant therapy in rectal cancer: a systematic review and meta-analysis of treatment outcomes. Ann Surg 2020;271:440–448.)| false
• Search Google Scholar
• Export Citation

Bahadoer RR, Dijkstra EA, van Etten B, et al. Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial. Lancet Oncol 2021;22:29–42.

• PubMed
Bahadoer RR, Dijkstra EA, van Etten B, Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial. Lancet Oncol 2021;22:29–42.)| false
• Search Google Scholar
• Export Citation

Conroy T, Bosset JF, Etienne PL, et al. Neoadjuvant chemotherapy with FOLFIRINOX and preoperative chemoradiotherapy for patients with locally advanced rectal cancer (UNICANCER-PRODIGE 23): a multicentre, randomised, open-label, phase 3 trial. Lancet Oncol 2021;22:702–715.

• PubMed
Conroy T, Bosset JF, Etienne PL, Neoadjuvant chemotherapy with FOLFIRINOX and preoperative chemoradiotherapy for patients with locally advanced rectal cancer (UNICANCER-PRODIGE 23): a multicentre, randomised, open-label, phase 3 trial. Lancet Oncol 2021;22:702–715.)| false
• Search Google Scholar
• Export Citation

Bujko K, Nowacki MP, Nasierowska-Guttmejer A, et al. Long-term results of a randomized trial comparing preoperative short-course radiotherapy with preoperative conventionally fractionated chemoradiation for rectal cancer. Br J Surg 2006;93:1215–1223.

• PubMed
Bujko K, Nowacki MP, Nasierowska-Guttmejer A, Long-term results of a randomized trial comparing preoperative short-course radiotherapy with preoperative conventionally fractionated chemoradiation for rectal cancer. Br J Surg 2006;93:1215–1223.)| false
• Search Google Scholar
• Export Citation

Latkauskas T, Pauzas H, Kairevice L, et al. Preoperative conventional chemoradiotherapy versus short-course radiotherapy with delayed surgery for rectal cancer: results of a randomized controlled trial. BMC Cancer 2016;16:927.

• PubMed
Latkauskas T, Pauzas H, Kairevice L, Preoperative conventional chemoradiotherapy versus short-course radiotherapy with delayed surgery for rectal cancer: results of a randomized controlled trial. BMC Cancer 2016;16:927.)| false
• Search Google Scholar
• Export Citation

Ngan SY, Burmeister B, Fisher RJ, et al. Randomized trial of short-course radiotherapy versus long-course chemoradiation comparing rates of local recurrence in patients with T3 rectal cancer: Trans-Tasman Radiation Oncology Group trial 01.04. J Clin Oncol 2012;30:3827–3833.

• PubMed
Ngan SY, Burmeister B, Fisher RJ, Randomized trial of short-course radiotherapy versus long-course chemoradiation comparing rates of local recurrence in patients with T3 rectal cancer: Trans-Tasman Radiation Oncology Group trial 01.04. J Clin Oncol 2012;30:3827–3833.)| false
• Search Google Scholar
• Export Citation

Ciseł B, Pietrzak L, Michalski W, et al. Long-course preoperative chemoradiation vs. 5 x 5 Gy and consolidation chemotherapy for clinical T4 and fixed clinical T3 rectal cancer: long-term results of the randomized Polish II study. Ann Oncol 2019;30:1298–1303.

• PubMed
Ciseł B, Pietrzak L, Michalski W, Long-course preoperative chemoradiation vs. 5 x 5 Gy and consolidation chemotherapy for clinical T4 and fixed clinical T3 rectal cancer: long-term results of the randomized Polish II study. Ann Oncol 2019;30:1298–1303.)| false
• Search Google Scholar
• Export Citation

Erlandsson J, Holm T, Pettersson D, et al. Optimal fractionation of preoperative radiotherapy and timing to surgery for rectal cancer (Stockholm III): a multicentre, randomised, non-blinded, phase 3, non-inferiority trial. Lancet Oncol 2017;18:336–346.

• PubMed
Erlandsson J, Holm T, Pettersson D, Optimal fractionation of preoperative radiotherapy and timing to surgery for rectal cancer (Stockholm III): a multicentre, randomised, non-blinded, phase 3, non-inferiority trial. Lancet Oncol 2017;18:336–346.)| false
• Search Google Scholar
• Export Citation

Jin J, Tang Y, Hu C, et al. Multicenter, randomized, phase III trial of short-term radiotherapy plus chemotherapy versus long-term chemoradiotherapy in locally advanced rectal cancer (STELLAR). J Clin Oncol 2022;40:1681–1692.

• PubMed
Jin J, Tang Y, Hu C, Multicenter, randomized, phase III trial of short-term radiotherapy plus chemotherapy versus long-term chemoradiotherapy in locally advanced rectal cancer (STELLAR). J Clin Oncol 2022;40:1681–1692.)| false
• Search Google Scholar
• Export Citation

Dijkstra EA, Nilsson PJ, Hospers GAP, et al. Locoregional failure during and after short-course radiotherapy followed by chemotherapy and surgery compared with long-course chemoradiotherapy and surgery: a 5-year follow-up of the RAPIDO trial. Ann Surg 2023;278:e766–772.

• PubMed
Dijkstra EA, Nilsson PJ, Hospers GAP, Locoregional failure during and after short-course radiotherapy followed by chemotherapy and surgery compared with long-course chemoradiotherapy and surgery: a 5-year follow-up of the RAPIDO trial. Ann Surg 2023;278:e766–772.)| false
• Search Google Scholar
• Export Citation

Smith JJ, Chow OS, Gollub MJ, et al. Organ Preservation in Rectal Adenocarcinoma: a phase II randomized controlled trial evaluating 3-year disease-free survival in patients with locally advanced rectal cancer treated with chemoradiation plus induction or consolidation chemotherapy, and total mesorectal excision or nonoperative management. BMC Cancer 2015;15:767.

• PubMed
Smith JJ, Chow OS, Gollub MJ, Organ Preservation in Rectal Adenocarcinoma: a phase II randomized controlled trial evaluating 3-year disease-free survival in patients with locally advanced rectal cancer treated with chemoradiation plus induction or consolidation chemotherapy, and total mesorectal excision or nonoperative management. BMC Cancer 2015;15:767.)| false
• Search Google Scholar
• Export Citation

Garcia-Aguilar J, Patil S, Gollub MJ, et al. Organ preservation in patients with rectal adenocarcinoma treated with total neoadjuvant therapy. J Clin Oncol 2022;40:2546–2556.

• PubMed
Garcia-Aguilar J, Patil S, Gollub MJ, Organ preservation in patients with rectal adenocarcinoma treated with total neoadjuvant therapy. J Clin Oncol 2022;40:2546–2556.)| false
• Search Google Scholar
• Export Citation

Fokas E, Allgauer M, Polat B, et al. Randomized phase II trial of chemoradiotherapy plus induction or consolidation chemotherapy as total neoadjuvant therapy for locally advanced rectal cancer: CAO/ARO/AIO-12. J Clin Oncol 2019;37:3212–3222.

• PubMed
Fokas E, Allgauer M, Polat B, Randomized phase II trial of chemoradiotherapy plus induction or consolidation chemotherapy as total neoadjuvant therapy for locally advanced rectal cancer: CAO/ARO/AIO-12. J Clin Oncol 2019;37:3212–3222.)| false
• Search Google Scholar
• Export Citation

Fokas E, Schlenska-Lange A, Polat B, et al. Chemoradiotherapy plus induction or consolidation chemotherapy as total neoadjuvant therapy for patients with locally advanced rectal cancer: long-term results of the CAO/ARO/AIO-12 randomized clinical trial. JAMA Oncol 2022;8:e215445.

• PubMed
Fokas E, Schlenska-Lange A, Polat B, Chemoradiotherapy plus induction or consolidation chemotherapy as total neoadjuvant therapy for patients with locally advanced rectal cancer: long-term results of the CAO/ARO/AIO-12 randomized clinical trial. JAMA Oncol 2022;8:e215445.)| false
• Search Google Scholar
• Export Citation

Lai LL, Fuller CD, Kachnic LA, Thomas CR Jr. Can pelvic radiotherapy be omitted in select patients with rectal cancer? Semin Oncol 2006;33:S70–74.

• PubMed
Lai LL, Fuller CD, Kachnic LA, Thomas CR Jr. Can pelvic radiotherapy be omitted in select patients with rectal cancer? Semin Oncol 2006;33:S70–74.)| false
• Search Google Scholar
• Export Citation

Peeters KC, van de Velde CJ, Leer JW, et al. Late side effects of short-course preoperative radiotherapy combined with total mesorectal excision for rectal cancer: increased bowel dysfunction in irradiated patients—a Dutch Colorectal Cancer Group study. J Clin Oncol 2005;23:6199–6206.

• PubMed
Peeters KC, van de Velde CJ, Leer JW, Late side effects of short-course preoperative radiotherapy combined with total mesorectal excision for rectal cancer: increased bowel dysfunction in irradiated patients—a Dutch Colorectal Cancer Group study. J Clin Oncol 2005;23:6199–6206.)| false
• Search Google Scholar
• Export Citation

Rahbari NN, Elbers H, Askoxylakis V, et al. Neoadjuvant radiotherapy for rectal cancer: meta-analysis of randomized controlled trials. Ann Surg Oncol 2013;20:4169–4182.

• PubMed
Rahbari NN, Elbers H, Askoxylakis V, Neoadjuvant radiotherapy for rectal cancer: meta-analysis of randomized controlled trials. Ann Surg Oncol 2013;20:4169–4182.)| false
• Search Google Scholar
• Export Citation

Deng Y, Chi P, Lan P, et al. Modified FOLFOX6 with or without radiation versus fluorouracil and leucovorin with radiation in neoadjuvant treatment of locally advanced rectal cancer: initial results of the Chinese FOWARC multicenter, open-label, randomized three-arm phase III trial. J Clin Oncol 2016;34:3300–3307.

• PubMed
Deng Y, Chi P, Lan P, Modified FOLFOX6 with or without radiation versus fluorouracil and leucovorin with radiation in neoadjuvant treatment of locally advanced rectal cancer: initial results of the Chinese FOWARC multicenter, open-label, randomized three-arm phase III trial. J Clin Oncol 2016;34:3300–3307.)| false
• Search Google Scholar
• Export Citation

Deng Y, Chi P, Lan P, et al. Neoadjuvant modified FOLFOX6 with or without radiation versus fluorouracil plus radiation for locally advanced rectal cancer: final results of the Chinese FOWARC trial. J Clin Oncol 2019;37:3223–3233.

• PubMed
Deng Y, Chi P, Lan P, Neoadjuvant modified FOLFOX6 with or without radiation versus fluorouracil plus radiation for locally advanced rectal cancer: final results of the Chinese FOWARC trial. J Clin Oncol 2019;37:3223–3233.)| false
• Search Google Scholar
• Export Citation

Schrag D, Shi Q, Weiser MR, et al. Preoperative treatment of locally advanced rectal cancer. N Engl J Med 2023;389:322–334.

• PubMed
Schrag D, Shi Q, Weiser MR, Preoperative treatment of locally advanced rectal cancer. N Engl J Med 2023;389:322–334.)| false
• Search Google Scholar
• Export Citation

Basch E, Dueck AC, Mitchell SA, et al. Patient-reported outcomes during and after treatment for locally advanced rectal cancer in the PROSPECT trial (Alliance N1048). J Clin Oncol 2023;41:3724–3734.

• PubMed
Basch E, Dueck AC, Mitchell SA, Patient-reported outcomes during and after treatment for locally advanced rectal cancer in the PROSPECT trial (Alliance N1048). J Clin Oncol 2023;41:3724–3734.)| false
• Search Google Scholar
• Export Citation

Mei WJ, Wang XZ, Li YF, et al. Neoadjuvant chemotherapy with CAPOX versus chemoradiation for locally advanced rectal cancer with uninvolved mesorectal fascia (CONVERT): initial results of a phase III trial. Ann Surg 2023;277:557–564.

• PubMed
Mei WJ, Wang XZ, Li YF, Neoadjuvant chemotherapy with CAPOX versus chemoradiation for locally advanced rectal cancer with uninvolved mesorectal fascia (CONVERT): initial results of a phase III trial. Ann Surg 2023;277:557–564.)| false
• Search Google Scholar
• Export Citation

Maas M, Beets-Tan RG, Lambregts DM, et al. Wait-and-see policy for clinical complete responders after chemoradiation for rectal cancer. J Clin Oncol 2011;29:4633–4640.

• PubMed
Maas M, Beets-Tan RG, Lambregts DM, Wait-and-see policy for clinical complete responders after chemoradiation for rectal cancer. J Clin Oncol 2011;29:4633–4640.)| false
• Search Google Scholar
• Export Citation

Appelt AL, Ploen J, Harling H, et al. High-dose chemoradiotherapy and watchful waiting for distal rectal cancer: a prospective observational study. Lancet Oncol 2015;16:919–927.

• PubMed
Appelt AL, Ploen J, Harling H, High-dose chemoradiotherapy and watchful waiting for distal rectal cancer: a prospective observational study. Lancet Oncol 2015;16:919–927.)| false
• Search Google Scholar
• Export Citation

Habr-Gama A, Gama-Rodrigues J, Sao Juliao GP, et al. Local recurrence after complete clinical response and watch and wait in rectal cancer after neoadjuvant chemoradiation: impact of salvage therapy on local disease control. Int J Radiat Oncol Biol Phys 2014;88:822–828.

• PubMed
Habr-Gama A, Gama-Rodrigues J, Sao Juliao GP, Local recurrence after complete clinical response and watch and wait in rectal cancer after neoadjuvant chemoradiation: impact of salvage therapy on local disease control. Int J Radiat Oncol Biol Phys 2014;88:822–828.)| false
• Search Google Scholar
• Export Citation

Li J, Liu H, Yin J, et al. Wait-and-see or radical surgery for rectal cancer patients with a clinical complete response after neoadjuvant chemoradiotherapy: a cohort study. Oncotarget 2015;6:42354–42361.

• PubMed
Li J, Liu H, Yin J, Wait-and-see or radical surgery for rectal cancer patients with a clinical complete response after neoadjuvant chemoradiotherapy: a cohort study. Oncotarget 2015;6:42354–42361.)| false
• Search Google Scholar
• Export Citation

Smith JJ, Strombom P, Chow OS, et al. Assessment of a watch-and-wait strategy for rectal cancer in patients with a complete response after neoadjuvant therapy. JAMA Oncol 2019;5:e185896.

• PubMed
Smith JJ, Strombom P, Chow OS, Assessment of a watch-and-wait strategy for rectal cancer in patients with a complete response after neoadjuvant therapy. JAMA Oncol 2019;5:e185896.)| false
• Search Google Scholar
• Export Citation

Dossa F, Chesney TR, Acuna SA, Baxter NN. A watch-and-wait approach for locally advanced rectal cancer after a clinical complete response following neoadjuvant chemoradiation: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol 2017;2:501–513.

• PubMed
Dossa F, Chesney TR, Acuna SA, Baxter NN. A watch-and-wait approach for locally advanced rectal cancer after a clinical complete response following neoadjuvant chemoradiation: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol 2017;2:501–513.)| false
• Search Google Scholar
• Export Citation

Sammour T, Price BA, Krause KJ, Chang GJ. Nonoperative management or 'watch and wait' for rectal cancer with complete clinical response after neoadjuvant chemoradiotherapy: a critical appraisal. Ann Surg Oncol 2017;24:1904–1915.

• PubMed
Sammour T, Price BA, Krause KJ, Chang GJ. Nonoperative management or 'watch and wait' for rectal cancer with complete clinical response after neoadjuvant chemoradiotherapy: a critical appraisal. Ann Surg Oncol 2017;24:1904–1915.)| false
• Search Google Scholar
• Export Citation

Kong JC, Guerra GR, Warrier SK, et al. Outcome and salvage surgery following “watch and wait” for rectal cancer after neoadjuvant therapy: a systematic review. Dis Colon Rectum 2017;60:335–345.

• PubMed
Kong JC, Guerra GR, Warrier SK, Outcome and salvage surgery following “watch and wait” for rectal cancer after neoadjuvant therapy: a systematic review. Dis Colon Rectum 2017;60:335–345.)| false
• Search Google Scholar
• Export Citation

van der Valk MJM, Hilling DE, Bastiaannet E, et al. Long-term outcomes of clinical complete responders after neoadjuvant treatment for rectal cancer in the International Watch & Wait Database (IWWD): an international multicentre registry study. Lancet 2018;391:2537–2545.

• PubMed
van der Valk MJM, Hilling DE, Bastiaannet E, Long-term outcomes of clinical complete responders after neoadjuvant treatment for rectal cancer in the International Watch & Wait Database (IWWD): an international multicentre registry study. Lancet 2018;391:2537–2545.)| false
• Search Google Scholar
• Export Citation

Fernandez LM, Sao Juliao GP, Figueiredo NL, et al. Conditional recurrence-free survival of clinical complete responders managed by watch and wait after neoadjuvant chemoradiotherapy for rectal cancer in the International Watch & Wait Database: a retrospective, international, multicentre registry study. Lancet Oncol 2021;22:43–50.

• PubMed
Fernandez LM, Sao Juliao GP, Figueiredo NL, Conditional recurrence-free survival of clinical complete responders managed by watch and wait after neoadjuvant chemoradiotherapy for rectal cancer in the International Watch & Wait Database: a retrospective, international, multicentre registry study. Lancet Oncol 2021;22:43–50.)| false
• Search Google Scholar
• Export Citation

Verheij FS, Omer DM, Williams H, et al. Long-term results of organ preservation in patients with rectal adenocarcinoma treated with total neoadjuvant therapy: the randomized phase II OPRA trial. J Clin Oncol 2024;42:500–506.

• PubMed
Verheij FS, Omer DM, Williams H, Long-term results of organ preservation in patients with rectal adenocarcinoma treated with total neoadjuvant therapy: the randomized phase II OPRA trial. J Clin Oncol 2024;42:500–506.)| false
• Search Google Scholar
• Export Citation

Thompson HM, Omer DM, Lin S, et al. Organ preservation and survival by clinical response grade in patients with rectal cancer treated with total neoadjuvant therapy: a secondary analysis of the OPRA randomized clinical trial. JAMA Netw Open 2024;7:e2350903.

• PubMed
Thompson HM, Omer DM, Lin S, Organ preservation and survival by clinical response grade in patients with rectal cancer treated with total neoadjuvant therapy: a secondary analysis of the OPRA randomized clinical trial. JAMA Netw Open 2024;7:e2350903.)| false
• Search Google Scholar
• Export Citation

Loria A, Ammann AM, Olowokure OO, et al. Systematic review of neoadjuvant immunotherapy for mismatch repair deficient locally advanced colon cancer: an emerging strategy. Dis Colon Rectum 2024;67:762–771.

• PubMed
Loria A, Ammann AM, Olowokure OO, Systematic review of neoadjuvant immunotherapy for mismatch repair deficient locally advanced colon cancer: an emerging strategy. Dis Colon Rectum 2024;67:762–771.)| false
• Search Google Scholar
• Export Citation

Wang QX, Xiao BY, Cheng Y, et al. Anti-PD-1-based immunotherapy as curative-intent treatment in dMMR/MSI-H rectal cancer: a multicentre cohort study. Eur J Cancer 2022;174:176–184.

• PubMed
Wang QX, Xiao BY, Cheng Y, Anti-PD-1-based immunotherapy as curative-intent treatment in dMMR/MSI-H rectal cancer: a multicentre cohort study. Eur J Cancer 2022;174:176–184.)| false
• Search Google Scholar
• Export Citation

Cercek A, Lumish M, Sinopoli J, et al. PD-1 blockade in mismatch repair-deficient, locally advanced rectal cancer. N Engl J Med 2022;386:2363–2376.

• PubMed
Cercek A, Lumish M, Sinopoli J, PD-1 blockade in mismatch repair-deficient, locally advanced rectal cancer. N Engl J Med 2022;386:2363–2376.)| false
• Search Google Scholar
• Export Citation

Cercek A, Sinopoli JC, Shia J, et al. Durable complete responses to PD-1 blockade alone in mismatch repair deficient locally advanced rectal cancer. J Clin Oncol 2024;42:Abstract LBA3512.

• PubMed
Cercek A, Sinopoli JC, Shia J, Durable complete responses to PD-1 blockade alone in mismatch repair deficient locally advanced rectal cancer. J Clin Oncol 2024;42:Abstract LBA3512.)| false
• Search Google Scholar
• Export Citation

Renehan AG, Malcomson L, Emsley R, et al. Watch-and-wait approach versus surgical resection after chemoradiotherapy for patients with rectal cancer (the OnCoRe project): a propensity-score matched cohort analysis. Lancet Oncol 2016;17:174–183.

• PubMed
Renehan AG, Malcomson L, Emsley R, Watch-and-wait approach versus surgical resection after chemoradiotherapy for patients with rectal cancer (the OnCoRe project): a propensity-score matched cohort analysis. Lancet Oncol 2016;17:174–183.)| false
• Search Google Scholar
• Export Citation